The European Aortic Data Collection (EADC) is a prospective, post-market, multi-centre observational study conducted across Europe.
The primary objective of the EADC is to collect patient-level data on Cook's custom-made devices (CMDs), also known as patient-specific devices. This data helps assess the clinical safety and performance of endovascular treatments for complex aortic disease using Cook's CMDs.
Since May 2023, the EADC has enrolled almost 800 patients across 18 sites with Prof. Stéphan Haulon serving as the principal investigator (PI).
In the video, Prof. Haulon discusses the study’s significance and the importance of collecting robust clinical data to evaluate product performance, drive innovation, and improve patient care.
Our heritage
Cook Medical’s heritage of innovation began decades ago in 1963 when our founder, Bill Cook, developed the fine art of listening—listening to physicians and identifying what they needed to get patients back to living better lives.
Our heritage of collaborating with physician pioneers has led to a legacy of creative, durability-by-design product development in the aortic clinical specialty.
Aortic disease
Aortic disease is currently an incurable, progressive condition with many complexities, which, if left untreated, could be life threatening. Since its inception, Cook Medical has been dedicated to providing a complete aortic therapies program, offering a portfolio of endovascular products and services that assist physicians in the management of aortic disease.
Latest News
Recently published data from the STABLE I and STABLE II trials supporting a composite device approach to endovascular treatment of TBAD. BY JOSEPH V. LOMBARDI, MD, AND QING ZHOU, PhD The management of type B aortic dissection (TBAD) has been…
In October 2018, Dr. Naoki Fujimura, a cardiovascular surgeon at Tokyo Saiseikai Central Hospital, in Japan, performed a thoracic endovascular aortic repair (TEVAR) in a patient with an aneurysm of the descending thoracic aorta, using Cook’s low-profile Zenith Alpha Thoracic…
Mathew Wooster, MD, is in his fifth and final year of the integrated residency program at the University of South Florida in Tampa. Dr. Wooster shares his experience with FEVAR as a fellow and how it has impacted his job… 
Martyn Knowles, MD, practices vascular surgery at UNC Rex Hospital in Raleigh, North Carolina. He shares his advice for establishing a FEVAR practice in a community setting. What is your practice like in Raleigh? Our group practices at a 650-bed,… 
Jesse Manunga, MD, is a vascular surgeon at Abbott Northwestern Hospital in Minneapolis, Minnesota. Dr. Manunga shares his thoughts on getting experience with FEVAR as a new attending and building a team to support the procedure. How did you start… 
[caption id="attachment_1613" align="alignleft" width="150"] Michael D. Dake, MD[/caption] This blog content derives from the January 2016 EVT Europe Supplement: Global Approaches To Type B Dissection article written by Michael D. Dake, MD. During the last 5 to 10 years, we… 
Understanding the effects on aortic remodeling and malperfusion. This blog content derives from the January 2016 EVT Europe Supplement: Global Approaches To Type B Dissection article written by Jonathan Sobocinski, MD, PhD; Nuno V. Dias, MD, PhD; Rachel Clough, MD, PhD;… 
[caption id="attachment_1497" align="alignleft" width="150"] Eric Verhoeven, MD, PhD[/caption] Eric Verhoeven, MD, PhD, is the chief of vascular and endovascular surgery at Klinikum Nürnberg in Nürnberg, Germany. Dr. Verhoeven shares his thoughts on dissection outcomes in the short- and long-term, and… 
[caption id="attachment_1607" align="alignleft" width="150"] Gianbattista Parlani, MD[/caption] Gianbattista Parlani, MD, is a vascular surgeon at the hospital S. Maria della Misericordia in Peruggia, Italy. Dr. Parlani shares his experience after 10 years preserving the hypogastric artery. Which patient population do… 
Christoph A. Nienaber, MD, PhD, is with Royal Brompton Hospital, Interventional Cardiology & Aortic Centre, The Royal Brompton & Harefield NHS Trust in London, United Kingdom. As a direct consequence of demographic changes and an aging population, along with an… 
Fabio Verzini, MD, PhD, is Professor of Vascular Surgery at University of Peruqia. Hospital Santa Maria della Misericordia Italy. Dr. Verzini shares his thoughts on durability of standard EVAR after publishing 14-year data. What are the goals of standard abdominal… 
Tilo Kölbel, MD, is professor of vascular surgery at University of Hamburg in Hamburg, Germany. Dr. Kölbel shares his experience treating dissection. How is the approach different for a patient with an aneurysm versus a dissection? There are a lot… 
Rachel Clough, MD, PhD, is an associate professor in the Aortic Centre at CHRU Lille, France. Dr. Clough shares her thoughts about taking an individualized approach to dissection treatment. Taking an “individualized approach to treatment” has been a hot topic… 
The Zenith Alpha Abdominal Endovascular Graft is the culmination of everything we have learned in more than 20 years of EVAR. Learn more about the details that went into the device design. Click the infographic to enlarge. Learn more about… 
The treatment paradigm for type B dissections is widely debated amongst physicians. In the latest supplement to Endovascular Today Europe, experts from around the globe discuss their approaches to treatment and explore various therapeutic strategies. Read the articles from the supplement… 
Achieve a seal in healthy tissue throughout the infrarenal and visceral aorta with Zenith abdominal endovascular grafts. View our products' indications for use, component ordering information, introduction system information, and graft specifications, or download the Zenith® Physician's Pocket Reference Guide.…